? What Is The Oncomine AML Panel Test?
The Oncomine AML Panel is a next-generation sequencing (NGS) test designed to detect genetic mutations and alterations linked to Acute Myeloid Leukemia (AML). It provides critical insights into the genetic profile of the disease, helping with diagnosis, prognosis, and selection of targeted therapies.

? Why Do People In Dubai Choose This Test?

✔️ Detects key mutations like FLT3, NPM1, IDH1, IDH2, CEBPA, RUNX1
✔️ Helps guide personalized treatment plans and clinical trial access
✔️ Supports risk classification and prognosis in AML cases
✔️ Preferred by hematologists and oncologists across Dubai
✔️ Ideal for newly diagnosed or relapsed AML patients

? Methodology Of The Test

1. Sample Collection:
   A blood sample or bone marrow aspirate is collected by a healthcare professional.

2. DNA & RNA Extraction:
   Genetic material is extracted from the sample for comprehensive sequencing.

3. NGS Sequencing & Analysis:
   The test uses high-throughput sequencing to analyze genes associated with AML and detect single nucleotide variants (SNVs), insertions/deletions (indels), and gene fusions.

4. Report & Interpretation:
   Results are delivered within 10–14 working days in a detailed report, aiding doctors in treatment planning and risk stratification.

? When Should You Take This Test?

• At initial diagnosis of Acute Myeloid Leukemia
• When relapse or progression is suspected
• To identify actionable mutations for therapy selection
• For prognostic risk assessment
• As part of a comprehensive leukemia work-up

? Cost Of Oncomine AML Panel In Dubai

The cost of this test typically ranges from AED 3,000 – AED 6,000, depending on the lab and the scope of gene coverage.

?‍♀️ Frequently Asked Questions (FAQ)

Q1: What genes are analyzed in the Oncomine AML Panel?
The panel includes critical AML-related genes such as FLT3, NPM1, DNMT3A, IDH1, IDH2, TP53, RUNX1, and others.

Q2: Is the test suitable for monitoring AML during treatment?
Yes, it helps monitor genetic changes during treatment or relapse, supporting therapy adjustments.

Q3: How is this test different from regular blood tests?
Unlike basic blood tests, this test analyzes deep genetic mutations to provide a molecular profile of leukemia.

Q4: Can this test be used for pediatric AML?
Yes, the test is suitable for both adults and children, depending on the oncologist’s recommendation.

Q5: Are results confidential?
Yes, all reports are handled with complete privacy and medical confidentiality.

✅ Conclusion
The Oncomine AML Panel Test is a powerful genomic tool for understanding, managing, and treating Acute Myeloid Leukemia. With its advanced genetic insights, it empowers oncologists to make informed, personalized treatment decisions. If you're in Dubai and dealing with an AML diagnosis or relapse, this test is a key step in getting accurate, effective care. Book your appointment at a trusted facility and take charge of your blood health today.